Whereas 8-bromo-cAMP promoted activation in the two AD cell lines, H1373 and H1781, 8-bromo-cGMP decreased the phosphorylation of AKT (Figure 4A and Figure S3). The gene discussed is AKT1; the disease is Alzheimer disease.